- 🔴 Insolvency / collective proceedings on file (4)
Think this is wrong? This is an automated estimate — request a human review or correction.
DA VOLTERRA
Public limited company (SA) · RC 431860758 · Active since 2000
Overview
DA VOLTERRA is a public limited company (sa) registered in France, since 2000. The company operates in the scientific research & development sector. With reported revenue of 14K EUR in 2020. Its TraceComp score of 74 (B+) indicates moderate risk with some areas to watch. With 26 years of operations, the company has an established track record in its market.
Company Information
- Registration Number
- 431860758
- Legal Form
- Public limited company (SA)
- Registered
- 2000-05-16
Financial Profile
Latest filed accounts: FY 2020 · most recent available in public filings
Multi-year financials & ratios
5 years of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.
What’s in the full report
- Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
- Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
- Insolvency & legal events — collective proceedings and adverse filings (where on record)
- Charges & secured lending — registered charges and the creditors entitled (where filed)
- Sanctions & screening — company-level watchlist & adverse signals
- Sector benchmark & peers — how the company compares to its sector and nearest peers
- Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Insolvency & Collective Proceedings
4 insolvency / collective-proceedings notices on file — most recent published 2024-03-08. A material adverse finding for counterparty and credit risk.
Insolvency notice types, titles, publication dates and official Gazette sources.
What’s in the full report
- Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
- Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
- Insolvency & legal events — collective proceedings and adverse filings (where on record)
- Charges & secured lending — registered charges and the creditors entitled (where filed)
- Sanctions & screening — company-level watchlist & adverse signals
- Sector benchmark & peers — how the company compares to its sector and nearest peers
- Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Research Output
Active research organization. 267 publications · 8,666 citations · h-index 48 in the global scholarly record (OpenAlex — 82.9M papers). Top fields by publication volume: Medicine (80%) · Biochemistry, Genetics and Molecular Biology (14%) · Engineering (6%).
See full research profile — top researchers & publications →
Source: OpenAlex (CC0). Objective publication & citation counts.
Patent Portfolio
Active patent holder. 11 patents · 10 active · 11 granted in the USPTO/EPO record.
See full patent portfolio — most-cited inventions & inventors →
Source: USPTO / EPO open patent data. Objective bibliographic counts.
Risk Signals
No adverse legal events have been recorded for this company.
- Net loss reported in FY 2020
- Altman Z-Score in the distress zone — elevated insolvency risk on the model
Data Sources & Freshness
Data sourced from: bulk register.